Chapter Diagnostics Inc.
Menlo Park, CA
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1455 Adams Dr #2162, Menlo Park, CA 94025, USA
- Website
- chapterdx.com
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $48,390 |
| FY2025 | $0 |
| FY2024 | $0 |
| FY2023 | $267,500 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Agriculture | $48,390 |
Contract awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Seqwell Inc. | Beverly, MA | 325414 Biological Product (except Diagnostic) Manufacturing |
| Pacific Biosciences Of California, Inc. | Menlo Park, CA | 334516 Analytical Laboratory Instrument Manufacturing |
| Illumina, Inc. | San Diego, CA | 334516 Analytical Laboratory Instrument Manufacturing |
| Zymo Research Corporation | Irvine, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Dovetail Genomics LLC | Scotts Valley, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Chapter Diagnostics Inc., a for-profit corporation headquartered in Menlo Park, California, develops and sells molecular diagnostic reagents, sequencing kits, and detection software to federal health and agriculture agencies as a prime contractor under small-business set-asides. The vendor operates exclusively as a prime on small-dollar purchase orders; it has no subcontract footprint and no seats on government-wide vehicles.
Chapter Diagnostics operates in applied life-sciences R&D and diagnostics manufacturing, with a narrow but concrete federal capability portfolio anchored in pathogen detection and sequencing. Recent work includes a $48,390 purchase order awarded by USDA's Plant Protection and Quarantine division on September 2, 2026, for ten ChapterDx PomePlex-26 NGS assay kits designed to detect 26 different pome tree pathogens simultaneously via multiplex PCR — each kit supplies reagents for 96 individual samples and replaces individual PCR diagnostics in plant certification programs. The Food and Drug Administration has issued two prior purchase orders: a $137,500 order (September 2023, completed October 2024) for development of hepatitis A virus sequencing reagents and baits, and a $130,000 order (July 2023, completed July 2024) for design and development of next-generation targeted sequencing reagents and software for Campylobacter detection and typing from food and environmental matrices.
Customer concentration is split between the Food and Drug Administration (two awards, $268,000 combined potential value) and USDA's Animal and Plant Health Inspection Service (one award, $48,000). The vendor's federal footprint spans three purchase orders over the past three years, with $316,000 combined potential value, all obligated. One award reaches ultimate completion in the next twenty-four months. No set-aside category recurs; the USDA award used a total small-business set-aside, while the two FDA awards carried no set-aside designation.
Quick answers
Is Chapter Diagnostics Inc. registered in SAM.gov?
Yes. Chapter Diagnostics Inc.'s SAM.gov registration is active through August 27, 2027.
What is Chapter Diagnostics Inc.'s CAGE code?
Chapter Diagnostics Inc.'s CAGE code is 8B7U4, and its Unique Entity ID (UEI) is XFHDFTAVBRM5.
How much has Chapter Diagnostics Inc. received in federal contracts?
Federal contracts obligated $315,890 to Chapter Diagnostics Inc. in fiscal years 2023 through 2027.
What is Chapter Diagnostics Inc.'s most recent federal award?
Chapter Diagnostics Inc.'s most recent federal contract award is These kits have been developed to detect 26 different pome pathogens simultaneously by multiplex PCR reactions (12639526P0253), from Marketing and Regulatory Programs Business Services (APHIS), on September 2, 2026.
On GovTribe
See Chapter Diagnostics Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors